SomnoMed Limited (SOM.AX)
AUD 0.48
(0.0%)
AUD 0.48
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -3.84 Million AUD | -104.52% |
| 2023 | -4.07 Million AUD | 1.42% |
| 2022 | -4.13 Million AUD | -534.26% |
| 2021 | -651.38 Thousand AUD | 30.78% |
| 2020 | -940.98 Thousand AUD | -202.45% |
| 2019 | 918.45 Thousand AUD | -54.19% |
| 2018 | 2 Million AUD | 153.68% |
| 2017 | -3.73 Million AUD | -3277.03% |
| 2016 | 117.55 Thousand AUD | 188.69% |
| 2015 | 40.72 Thousand AUD | -87.06% |
| 2014 | 314.7 Thousand AUD | 53.89% |
| 2013 | 204.5 Thousand AUD | -55.42% |
| 2012 | 458.71 Thousand AUD | -12.04% |
| 2011 | 521.51 Thousand AUD | 2750.41% |
| 2010 | 18.29 Thousand AUD | 100.93% |
| 2009 | -1.96 Million AUD | 31.48% |
| 2008 | -2.87 Million AUD | 23.47% |
| 2007 | -3.75 Million AUD | 17.56% |
| 2006 | -4.55 Million AUD | -25.39% |
| 2005 | -3.63 Million AUD | -544.43% |
| 2004 | -563.65 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -8.31 Million AUD | -104.2% |
| 2024 Q4 | -4.32 Million AUD | 0.0% |
| 2024 Q2 | -4.51 Million AUD | 0.0% |
| 2023 Q4 | -1.99 Million AUD | 0.0% |
| 2023 Q2 | -2.07 Million AUD | 0.0% |
| 2023 FY | -4.07 Million AUD | 1.42% |
| 2022 Q2 | -2.61 Million AUD | 0.0% |
| 2022 Q4 | -1.51 Million AUD | 0.0% |
| 2022 FY | -4.13 Million AUD | -534.26% |
| 2021 FY | -651.38 Thousand AUD | 30.78% |
| 2021 Q2 | 742.87 Thousand AUD | 0.0% |
| 2021 Q4 | -1.39 Million AUD | 0.0% |
| 2020 Q2 | 1.45 Million AUD | 0.0% |
| 2020 Q4 | -2.39 Million AUD | 0.0% |
| 2020 FY | -940.98 Thousand AUD | -202.45% |
| 2019 Q4 | 878.14 Thousand AUD | 0.0% |
| 2019 FY | 918.45 Thousand AUD | -54.19% |
| 2019 Q2 | 40.31 Thousand AUD | 0.0% |
| 2018 FY | 2 Million AUD | 153.68% |
| 2018 Q2 | 121.9 Thousand AUD | 0.0% |
| 2018 Q4 | 1.88 Million AUD | 0.0% |
| 2017 Q2 | -383.57 Thousand AUD | 0.0% |
| 2017 FY | -3.73 Million AUD | -3277.03% |
| 2017 Q4 | -3.35 Million AUD | 0.0% |
| 2016 Q2 | 274.38 Thousand AUD | 0.0% |
| 2016 Q4 | -156.82 Thousand AUD | 0.0% |
| 2016 FY | 117.55 Thousand AUD | 188.69% |
| 2015 FY | 40.72 Thousand AUD | -87.06% |
| 2015 Q4 | -1128.00 AUD | 0.0% |
| 2015 Q2 | 41.84 Thousand AUD | 0.0% |
| 2014 FY | 314.7 Thousand AUD | 53.89% |
| 2014 Q4 | -36.84 Thousand AUD | 0.0% |
| 2014 Q2 | 351.55 Thousand AUD | 0.0% |
| 2013 Q2 | 385.19 Thousand AUD | 0.0% |
| 2013 FY | 204.5 Thousand AUD | -55.42% |
| 2013 Q4 | -180.69 Thousand AUD | 0.0% |
| 2012 Q4 | 114.67 Thousand AUD | 0.0% |
| 2012 Q1 | 130.37 Thousand AUD | 0.0% |
| 2012 Q3 | 114.67 Thousand AUD | 0.0% |
| 2012 FY | 458.71 Thousand AUD | -12.04% |
| 2012 Q2 | 114.67 Thousand AUD | -12.04% |
| 2011 FY | 521.51 Thousand AUD | 2750.41% |
| 2011 Q1 | 4574.00 AUD | 0.0% |
| 2011 Q2 | 130.37 Thousand AUD | 2750.39% |
| 2011 Q3 | 130.37 Thousand AUD | 0.0% |
| 2011 Q4 | 130.37 Thousand AUD | 0.0% |
| 2010 Q4 | 4574.00 AUD | 0.0% |
| 2010 Q1 | -492.23 Thousand AUD | 0.0% |
| 2010 Q2 | 4574.00 AUD | 100.93% |
| 2010 Q3 | 4574.00 AUD | 0.0% |
| 2010 FY | 18.29 Thousand AUD | 100.93% |
| 2009 Q1 | -718.35 Thousand AUD | 0.0% |
| 2009 Q3 | -492.23 Thousand AUD | 0.0% |
| 2009 Q4 | -492.23 Thousand AUD | 0.0% |
| 2009 FY | -1.96 Million AUD | 31.48% |
| 2009 Q2 | -492.23 Thousand AUD | 31.48% |
| 2008 Q4 | -718.35 Thousand AUD | 0.0% |
| 2008 Q3 | -718.35 Thousand AUD | 0.0% |
| 2008 Q2 | -718.35 Thousand AUD | 15.67% |
| 2008 Q1 | -851.88 Thousand AUD | 0.0% |
| 2008 FY | -2.87 Million AUD | 23.47% |
| 2007 Q1 | -1.1 Million AUD | 0.0% |
| 2007 FY | -3.75 Million AUD | 17.56% |
| 2007 Q3 | -851.88 Thousand AUD | 0.0% |
| 2007 Q4 | -851.88 Thousand AUD | 0.0% |
| 2007 Q2 | -851.88 Thousand AUD | 22.78% |
| 2006 Q3 | -1.1 Million AUD | 0.0% |
| 2006 Q2 | -1.1 Million AUD | -21.48% |
| 2006 Q4 | -1.1 Million AUD | 0.0% |
| 2006 FY | -4.55 Million AUD | -25.39% |
| 2006 Q1 | -908.09 Thousand AUD | 0.0% |
| 2005 Q4 | -908.09 Thousand AUD | 0.0% |
| 2005 FY | -3.63 Million AUD | -544.43% |
| 2005 Q3 | -908.09 Thousand AUD | 0.0% |
| 2005 Q1 | -140.91 Thousand AUD | 0.0% |
| 2005 Q2 | -908.09 Thousand AUD | -544.43% |
| 2004 Q2 | -140.91 Thousand AUD | 0.0% |
| 2004 Q4 | -140.91 Thousand AUD | 0.0% |
| 2004 FY | -563.65 Thousand AUD | 0.0% |
| 2004 Q3 | -140.91 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 86.265% |
| Adherium Limited | -11.98 Million AUD | 67.95% |
| Aroa Biosurgery Limited | -9.78 Million AUD | 60.754% |
| Atomo Diagnostics Limited | -4.36 Million AUD | 11.927% |
| Anteris Technologies Ltd | -66.63 Million AUD | 94.235% |
| Control Bionics Limited | -5.92 Million AUD | 35.215% |
| CardieX Limited | -4.63 Million AUD | 17.101% |
| Compumedics Limited | -269 Thousand AUD | -1327.991% |
| Cochlear Limited | 521.5 Million AUD | 100.737% |
| CleanSpace Holdings Limited | -4.81 Million AUD | 20.205% |
| Cyclopharm Limited | -9.22 Million AUD | 58.358% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -137.938% |
| Nova Eye Medical Limited | -3.79 Million AUD | -1.167% |
| HeraMED Limited | -6.42 Million AUD | 40.241% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 78.144% |
| ImpediMed Limited | -19.03 Million AUD | 79.821% |
| InhaleRx Limited | -1.38 Million AUD | -177.052% |
| LBT Innovations Limited | -4.74 Million AUD | 18.96% |
| Micro-X Limited | -13.02 Million AUD | 70.513% |
| Neurotech International Limited | -5.58 Million AUD | 31.219% |
| OncoSil Medical Limited | -11.98 Million AUD | 67.947% |
| PolyNovo Limited | 1.16 Million AUD | 430.292% |
| Respiri Limited | -7 Million AUD | 45.126% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 76.971% |
| Uscom Limited | -2.4 Million AUD | -59.764% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | 34.383% |